Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 4297

1.

Differences between childhood- and adulthood-onset inflammatory bowel disease: the CAROUSEL study from GETECCU.

Chaparro M, Garre A, Ricart E, Iglesias-Flores E, Taxonera C, Domènech E, Gisbert JP; ENEIDA study group.

Aliment Pharmacol Ther. 2019 Jan 13. doi: 10.1111/apt.15114. [Epub ahead of print]

PMID:
30637837
2.

What is the Healthy Gut Microbiota Composition? A Changing Ecosystem across Age, Environment, Diet, and Diseases.

Rinninella E, Raoul P, Cintoni M, Franceschi F, Miggiano GAD, Gasbarrini A, Mele MC.

Microorganisms. 2019 Jan 10;7(1). pii: E14. doi: 10.3390/microorganisms7010014. Review.

3.

Inflammatory bowel disease and new-onset psychiatric disorders in pregnancy and post partum: a population-based cohort study.

Vigod SN, Kurdyak P, Brown HK, Nguyen GC, Targownik LE, Seow CH, Kuenzig ME, Benchimol EI.

Gut. 2019 Jan 9. pii: gutjnl-2018-317610. doi: 10.1136/gutjnl-2018-317610. [Epub ahead of print]

PMID:
30630948
4.

Change in Prevalence of Family History During Long-term Follow-up of Pediatric-onset Inflammatory Bowel Disease Patients.

Capone K, Rosenberg HJ, Wroblewski K, Gokhale R, Kirschner BS.

J Pediatr Gastroenterol Nutr. 2019 Jan 4. doi: 10.1097/MPG.0000000000002253. [Epub ahead of print]

PMID:
30628987
5.

Selective Tyk2 inhibitors as potential therapeutic agents: a patent review (2015-2018).

He X, Chen X, Zhang H, Xie T, Ye XY.

Expert Opin Ther Pat. 2019 Jan 8. doi: 10.1080/13543776.2019.1567713. [Epub ahead of print]

PMID:
30621465
6.

Novel PLCG2 Mutation in a Patient With APLAID and Cutis Laxa.

Neves JF, Doffinger R, Barcena-Morales G, Martins C, Papapietro O, Plagnol V, Curtis J, Martins M, Kumararatne D, Cordeiro AI, Neves C, Borrego LM, Katan M, Nejentsev S.

Front Immunol. 2018 Dec 14;9:2863. doi: 10.3389/fimmu.2018.02863. eCollection 2018.

7.

Zeaxanthin exerts protective effects on acetic acid-induced colitis in rats via modulation of pro-inflammatory cytokines and oxidative stress.

El-Akabawy G, El-Sherif NM.

Biomed Pharmacother. 2019 Jan 4;111:841-851. doi: 10.1016/j.biopha.2019.01.001. [Epub ahead of print]

PMID:
30616083
8.

Anxiety But Not Depression Predicts Poor Outcomes in Inflammatory Bowel Disease.

Narula N, Pinto-Sanchez MI, Calo NC, Ford AC, Bercik P, Reinisch W, Moayyedi P.

Inflamm Bowel Dis. 2019 Jan 7. doi: 10.1093/ibd/izy385. [Epub ahead of print]

PMID:
30615113
9.

Characteristics of Inflammatory Bowel Disease in patients of Roma/Gypsy ethnicity. A case-control study.

Cabré E, Mañosa M, Marín I, Martín-Mateos R, Iglesias-Flores E, Barreiro-de-Acosta M, Nos P, Busquets D, Menchén LA, López-Sanromán A, Domènech E.

Dig Liver Dis. 2018 Dec 19. pii: S1590-8658(18)31279-9. doi: 10.1016/j.dld.2018.12.004. [Epub ahead of print]

PMID:
30606697
10.

Immunohistochemical Profile of Tumor Suppressor Proteins RASSF1A and LATS1/2 in Relation to p73 and YAP Expression, of Human Inflammatory Bowel Disease and Normal Intestine.

Nterma P, Panopoulou E, Papadaki-Petrou E, Assimakopoulou M.

Pathol Oncol Res. 2019 Jan 2. doi: 10.1007/s12253-018-00575-z. [Epub ahead of print]

PMID:
30604274
11.

Paraneoplastic Encephalopathy in a Patient With Metastatic Lung Cancer: A Case Study.

Rowley SM.

J Adv Pract Oncol. 2018 Mar;9(2):216-221. Epub 2018 Mar 1. Review.

12.

Secondary amyloidosis associated with heroin use and recurrent infections - A case report.

Mani D.

Ann Med Surg (Lond). 2018 Nov 22;37:38-41. doi: 10.1016/j.amsu.2018.11.013. eCollection 2019 Jan.

13.

NOD1 and NOD2 in inflammation, immunity and disease.

Mukherjee T, Hovingh ES, Foerster EG, Abdel-Nour M, Philpott DJ, Girardin SE.

Arch Biochem Biophys. 2018 Dec 19. pii: S0003-9861(18)30937-8. doi: 10.1016/j.abb.2018.12.022. [Epub ahead of print] Review.

PMID:
30578751
14.

[Treg/Th17 balance and immunology of schistosome infection: a review].

Yan-Ru G, Wei-Wen C, Jia-Wang L, Hui-Lan Z.

Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2018 Oct 17;30(5):588-591. doi: 10.16250/j.32.1374.2018001. Chinese.

PMID:
30567041
15.

Genomic variation and strain-specific functional adaptation in the human gut microbiome during early life.

Vatanen T, Plichta DR, Somani J, Münch PC, Arthur TD, Hall AB, Rudolf S, Oakeley EJ, Ke X, Young RA, Haiser HJ, Kolde R, Yassour M, Luopajärvi K, Siljander H, Virtanen SM, Ilonen J, Uibo R, Tillmann V, Mokurov S, Dorshakova N, Porter JA, McHardy AC, Lähdesmäki H, Vlamakis H, Huttenhower C, Knip M, Xavier RJ.

Nat Microbiol. 2018 Dec 17. doi: 10.1038/s41564-018-0321-5. [Epub ahead of print]

PMID:
30559407
16.

Intestinal Anti-Inflammatory Activity of the Aqueous Extract from Ipomoea asarifolia in DNBS-Induced Colitis in Rats.

da Silva VC, de Araújo AA, de Souza Araújo DF, Souza Lima MCJ, Vasconcelos RC, de Araújo Júnior RF, Langasnner SMZ, de Freitas Fernandes Pedrosa M, de Medeiros CACX, Guerra GCB.

Int J Mol Sci. 2018 Dec 12;19(12). pii: E4016. doi: 10.3390/ijms19124016.

17.

The loss of tolerance to CHI3L1 - A putative role in inflammatory bowel disease?

Deutschmann C, Roggenbuck D, Schierack P.

Clin Immunol. 2018 Dec 10. pii: S1521-6616(18)30713-7. doi: 10.1016/j.clim.2018.12.005. [Epub ahead of print] Review.

PMID:
30543919
18.

Reversible senescence of human colon cancer cells after blockage of mitosis/cytokinesis caused by the CNF1 cyclomodulin from Escherichia coli.

Zhang Z, Aung KM, Uhlin BE, Wai SN.

Sci Rep. 2018 Dec 12;8(1):17780. doi: 10.1038/s41598-018-36036-5.

19.

INFLAMMATORY BOWEL DISEASE: IMPACT ON SCORES OF QUALITY OF LIFE, DEPRESSION AND ANXIETY IN PATIENTS ATTENDING A TERTIARY CARE CENTER IN BRAZIL.

Calixto RP, Flores C, Francesconi CF.

Arq Gastroenterol. 2018 Jul-Sep;55(3):202-207. doi: 10.1590/S0004-2803.201800000-54.

20.

Anti-claudin antibodies as a concept for development of claudin-directed drugs.

Hashimoto Y, Okada Y, Shirakura K, Tachibana K, Sawada M, Yagi K, Doi T, Kondoh M.

J Pharmacol Exp Ther. 2018 Dec 7. pii: jpet.118.252361. doi: 10.1124/jpet.118.252361. [Epub ahead of print]

Supplemental Content

Loading ...
Support Center